期刊名称：INTERNATIONAL IMMUNOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
|
International Immunology publishes a broad range of experimental and theoretical studies in molecular and cellular immunology conducted in laboratories throughout the world.
Impact Factor
3.595 (2002)
3.611 (2001)
3.130 (2000)
2.979 (1999) |
Instructions to Authors
Instructions to authors
International Immunology can now accept submissions online. Please see the detailed instructions page.
GENERAL
International Immunology will publish a broad range of experimental and theoretical studies in molecular and cellular immunology conducted in laboratories throughout the world. The editorial procedures of International Immunology are designed to involve a large and geographically diverse group of Transmitting Editors and Editorial Board members, each specialists in their own fields, who help to decide which papers are accepted for publication. Through the most careful selection of papers published, International Immunology will provide a concentrated source of leading research in the international field.
There will be no page charges, although payment for colour illustrations will be required. The URL of each contribution will be provided free of charge.
TYPES OF PAPERS ACCEPTED
The main part of each issue will be devoted to original research papers which should present new results of interest to a broad spectrum of immunologists. These must describe significant and original observations to be critically evaluated and, if necessary, repeated. Papers describing only specialized methods are not acceptable unless they contain meaningful results obtained with the methods. The mere description of a new monoclonal antibody or a protein/DNA sequence is generally unacceptable unless it has a strong implication.
The journal will include critical essays or minireviews that deal with particular subject areas in a thoughtful and personal manner. Subjects that are undergoing rapid change or that merit a new conceptual approach will be particularly suited to this treatment. They are generally commissioned by the Editor-in-Chief or Editorial Board Members. Authors who wish to submit papers of this type should first discuss their plan with appropriate members of the Editorial Board.
There will be a Fast Track section in which short and definitive papers of outstanding quality and urgency will be sent directly to the Editor-in Chief and decided upon rapidly. The paper will be reviewed first by the Editor-in-Chief. When the Editor-in-Chief considers that the paper has neither outstanding quality nor the need of urgent publication, the paper will be immediately returned to the author(s) as inappropriate without any referees¡¯ comments. When the paper is considered to be a potential Fast Track paper, the paper will be sent to two external referees, and the Editor-in-Chief will make the final decision and notify the acceptance or rejection of the paper within one month. A rejected Fast Track paper may be re-submitted as a regular article.
The journal will publish only new material. Submission of a paper will be taken to imply that it reports unpublished work and that it is not being considered for publication elsewhere. Furthermore, such submission will also be taken to imply that, if the paper is published, hybridomas, cell lines, gene clones, rDNA constructs, etc., used in the studies described therein will be made available to interested investigators for their use only in their own research. There is no absolute restriction on length.
SUBMISSION OF MANUSCRIPTS
International Immunology can now accept submissions online. Please see the detailed instructions page. Manuscripts, written in English, should be submitted to one of the Transmitting Editors (PDF file).
Contributors are asked to send their papers to Transmitting Editors outside their own institution whenever possible. As each Transmitting Editor is allowed to transmit up to 6 papers per volume, authors should contact the Transmitting Editor by e-mail, fax or telephone prior to submitting the paper to ascertain whether he/she can transmit the paper within the year. For hard copy submissions, three copies of the manuscript and illustrations should be sent to the Transmitting Editor chosen, together with a floppy disk containing the text file. Notification of submission should be made by sending a copy of the title page and abstract to the Editor-in-Chief, Dr Tadamitsu Kishimoto, Editorial Office, International Immunology, c/o The Research Foundation for Microbial Diseases of Osaka University, 3-1 Yamada-oka, Suita, Osaka 565-0871, Japan (Fax: +81-6-6816-3765). The Editor-in-Chief will inform you of your registration number in return. Failure to make this notification may cause a delay in publication. A decision will be communicated by one of the Editorial Board. Manuscripts should not be sent directly to any member of the Editorial Board.
Authors should keep copies of all material submitted. Manuscripts will not be returned and original artwork will only be returned if this is specifically requested. There is no absolute restriction on length.
REVIEWING PROCESS
It is the policy of the journal to represent the whole immunological community. The reviewing system is devised for rapid reaction by means of the large number of Transmitting Editors, whilst preventing the dominance of a few major institutions by ensuring that no paper is accepted which has not been looked at by at least one referee from another centre. The paper will be read by two external referees, and the Transmitting Editor will ask authors for revision, if necessary. An Editorial Board Member or the Editor-in-Chief will finally decide and notify the acceptance or rejection of the paper upon recommendation by the Transmitting Editor.
PREPARATION OF MANUSCRIPTS
All manuscripts should be double spaced throughout (including figure legends and references) and with 2.5 cm margins. Pages should be numbered sequentially in the upper right corner, including all typed material in the numbering. One set of publication quality figures and two copies of the figures should be sent. If the figures are photographs, all three sets should be of publication quality. Manuscripts that do not conform to these specifications may not be accepted, at the Editor's discretion.
The title page must include the following: title, full first name and surname of each contributor followed by name, full postal address, e-mail address and fax/telephone numbers of the contributor who will deal with correspondence including proofs; and a running title not in excess of 50 characters. The total number of pages and figures being submitted should also be indicated on this page. The name of the Transmitting Editor to whom the manuscript has been sent should be placed at the top right hand corner.
A maximum of five keywords not appearing in the title should be provided for use by indexing services.
Research papers should start with an ABSTRACT which will appear before the main body of the text. It should be written in complete sentences and should summarize the materials, methods, results, and major conclusions in 250 words or less in a form comprehensible to any immunologist and suitable for abstracting services. If references are used in an abstract, they must include the author(s), journal title, volume number, starting page, and year. Avoid abbreviations in abstracts as far as possible.
The main part of a research paper should start with a brief INTRODUCTION, which outlines the historical or logical origins of the study without repeating the abstract or summarizing the results, a section on METHODS, and one on RESULTS in which the observations are presented with minimal reference to earlier literature or to possible interpretations. The final DISCUSSION may usefully start with a brief summary of the major findings, but repetition of parts of the results section should be avoided.
All Supplier locations (city and country) must be given for any reagents/equipment used.
An alphabetized list of Abbreviations used in the text must be provided on a separate page.
Acknowledgements should follow the main text. Grants or contribution numbers can be acknowledged.
Tables should be numbered with Arabic numberals in the order that they appear in the text. Footnotes to tables should be included with the table. There should be an indication in the main text of the most appropriate placement of each table and illustration.
REFERENCES
References are to be cited in the text by a number in parentheses and should be numbered in order of first appearance. An example is: 'McMichael and Gotch (12) have reported . . .'. Where there are more than two authors, the citation in the text should use the formulation 'et al.'. An example is: 'This observation has been reported by Shackelford et al. (24)'.
In the list of references papers from journals should be listed thus:
24 Shackelford, D. A., Smith, A. V., and Trowbridge, I. S. 1987. Changes in gene expression induced by a phorbol diester: expression of IL2 receptor, T3, and T cell antigen receptor. J. Immunol. 138:613.
Books should be listed in one of the following styles:
12 McMichael, A. J. and Gotch, F. 1987. T-cell antigens: new and previously defined clusters. In McMichael, A. J., ed., Leukocyte Typing III, p. 31. Oxford University Press, Oxford.
28 Bowry, T. R. 1984. Immunology Simplified, 2nd edn. Oxford University Press, Oxford.
The titles of journals should be abbreviated in accordance with the World List of Scientific Periodicals, 4th edn.
ILLUSTRATIONS
Each figure should be relevant to the text and figures should be presented in the order in which they are mentioned in the text. Figures and photographs should be numbered as a single series and should contain the manuscript number and figure number.
Electronic files of figures accepted for publication must be saved with the extension .tif at a resolution of at least 300 d.p.i. at the final printed size (86 mm wingle and 178 mm double column width) for colour and half-tone figures and 1200 d.p.i. for black and white line drawings. Colour figures must be supplied in CMYK format rather than RGB. Hard copy figures should be supplied larger than the final size on the printed page; lettering should be in proportion, ideally providing characters 2 mm high on the printed page. Figure parts should be labelled upper case A, B, etc., in the top left hand corner.
Figure legends should explain each figure as fully as possible, referring the reader to the text only on rare occasions in order to avoid repeating in the legends material that must be included in the text. All abbreviations used in the figures should be explained in each legend where possible. When large numbers of abbreviations are necessary in the figures, the authors should include these in a separate list of abbreviations.
FACS data. Clearly identify the parameter for each axis, e.g. forward scatter, CD4, propidium iodide. Draw appropriate gates on the figures when pertinent.
COPYRIGHT
It is a condition of publication in the Journal that authors assign copyright to Oxford University Press. This ensures that requests from third parties to reproduce articles are handled efficiently and consistently and will also allow the article to be as widely disseminated as possible. In assigning copyright, authors may use their own material in other publications provided that the Journal is acknowledged as the original place of publication.
SUPPLEMENTARY DATA
Supporting material that is not essential for inclusion in the full text of the manuscript, but would nevertheless benefit the reader, can be made available by the publisher as online-only content, linked to the online manuscript. The material should not be essential to understanding the conclusions of the paper, but should contain data that is additional or complementary and directly relevant to the article content. Such information might include more detailed methods, extended data sets/data analysis, or additional figures (including colour). All text and figures must be provided in suitable electronic formats (instructions for the preparation of Supplementary Data can be viewed here). All material to be considered as Supplementary Data must be submitted at the same time as the main manuscript for peer review. It cannot be altered or replaced after the paper has been accepted for publication. Please indicate clearly the material intended as Supplementary Data upon submission. Also ensure that the Supplementary Data is referred to in the main manuscript where necessary.
Editorial Board
Founding Editor
T Tada, Japan
Editor-in-Chief
T Kishimoto, Japan
Associate Editors
S. Akira, Japan
H Kikutani, Japan
K Takatsu, Japan
Editorial Board
F W Alt, USA,
M D Cooper, USA
A Fischer, France
T Honjo, Japan
T W Mak, Canada
P Marrack, USA
A McMichael, UK
F Melchers, Switzerland
K Rajewsky, Germany
K Shortman, Australia
M Taniguchi, Japan
E R Unanue, USA
H Wigzell, Sweden
R Zinkernagel, Switzerland
Editorial Office
International Immunology
c/o The Research Foundation for Microbial
Diseases of Osaka University
3-1 Yamada-oka, Suita
Osaka 565-0871
Japan
E-mail: iieditor@ragtime.biken.osaka-u.ac.jp
List of Transmitting Editors.
| 
